This conventional concept of GRP94 as protein folding chaperone is updated by the discoveries that GRPs promote tumor proliferation, metastasis, drug resistance, and immunotherapy, which have major clinical implications in the prognosis and treatment of cancer [3]. This evidence concerns the gene HSP90B1 and neoplasm.